Surrey Heartlands

Joint Formulary & PAD

Naltrexone with bupropion - Weight management in adults

You are here : Home > Formulary Search > Naltrexone with bupropion - Weight management in adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NFD1
NICE
Restrictions / Comments :

Documentation

NICE Technology Appraisal
NICE TA494 - Naltrexone–bupropion for managing overweight and obesity

PAD Profile

ChemicalSubstance :
Naltrexone with bupropion
Indication :
Weight management in adults
Group Name :
Keywords :
weight loss, obesity, overweight
Brand Names Include :
Mysimba
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Naltrexone with bupropion is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Weight management in adults.

Committee Recommendations (1)

22 Jan 18 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Prescribing Clinical Network does not recommend the use of Naltrexone-bupropion for managing overweight and obesity. This is in line with NICE TA494. Naltrexone-bupropion will be considered BLACK on the traffic light status for all new patients. This recommendation is not intended to affect treatment with naltrexone–bupropion that was started in the NHS before this guidance was published. Adults having treatment outside this recommendation may continue without change to the funding arrangements in place for them before this guidance was published, until they and their NHS clinician consider it appropriate to stop.